YI1 A Century of Progress in Thyroid Physiology and Disease

Program: Endocrine "Year In" Sessions
Clinical Session
Friday, April 1, 2016: 11:30 AM-12:30 PM
Hall B2 (BCEC)
Speaker:
Paul W Ladenson, MD, Johns Hopkins Univ Sch of Med, Baltimore, MD

Disclosures:
PWL: Advisory Group Member, Viking Therapeutics, Inc., Advisory Group Member, Veracyte, Inc., Consultant, Expert Appointment, Inc..

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire